Acute poliomyelitis due to poliovirus, vaccine-associated
Chapter 1:Certain infectious and parasitic diseases
ICD-10 A80.3 is a billable code used to indicate a diagnosis of acute poliomyelitis due to poliovirus, vaccine-associated.
Acute poliomyelitis due to poliovirus, vaccine-associated, refers to a rare neurological condition that can occur following the administration of live attenuated oral poliovirus vaccine (OPV). This condition is characterized by the inflammation of the spinal cord and brain, leading to muscle weakness, paralysis, and other neurological complications. Vaccine-associated poliomyelitis typically arises in individuals who have received the OPV, particularly in immunocompromised patients or those with underlying health conditions that may predispose them to adverse reactions. The clinical presentation may include sudden onset of flaccid paralysis, fever, and muscle weakness, often affecting the lower limbs. Diagnosis is confirmed through clinical evaluation, history of vaccination, and laboratory tests, including viral isolation from stool or cerebrospinal fluid (CSF). It is crucial for healthcare providers to differentiate vaccine-associated poliomyelitis from wild poliovirus infections, as the management and public health implications differ significantly. The incidence of vaccine-associated poliomyelitis has decreased significantly with the global shift towards inactivated poliovirus vaccine (IPV) in many countries, but awareness and accurate coding remain essential for monitoring and epidemiological purposes.
Detailed neurological examination findings, vaccination history, and symptom onset.
Patients presenting with acute flaccid paralysis following OPV administration.
Ensure thorough documentation of neurological deficits and any relevant imaging or laboratory results.
History of vaccination, laboratory confirmation of poliovirus type, and clinical presentation.
Patients with suspected vaccine-associated poliomyelitis requiring differential diagnosis from other viral infections.
Document any immunocompromised status and potential exposure history.
Used for confirming the presence of poliovirus in CSF or stool samples.
Document the reason for testing and the clinical presentation.
Neurology and Infectious Disease specialists should ensure comprehensive documentation of clinical findings.
Vaccine-associated poliomyelitis occurs due to the live attenuated virus in the OPV reverting to a neurovirulent form, while wild poliovirus poliomyelitis is caused by naturally occurring strains of the virus. Accurate coding requires knowledge of the patient's vaccination history.
